Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Recruiting 4Completed 3Active not recruiting 1

Sponsor Class

INDUSTRY 4OTHER 2

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Dermatologic 3

Conditions

Carcinoma, Non-Small-Cell Lung 429Breast Neoplasms 298Neoplasms 296Colorectal Neoplasms 242Neoplasm Metastasis 197Ovarian Neoplasms 171Lung Neoplasms 150Recurrence 147Prostatic Neoplasms 146Pancreatic Neoplasms 142Multiple Myeloma 136Stomach Neoplasms 129Squamous Cell Carcinoma of Head and Neck 128Melanoma 123Leukemia, Myeloid, Acute 115Endometrial Neoplasms 115Advanced Solid Tumors 113Advanced Solid Tumor 108Carcinoma, Hepatocellular 102Triple Negative Breast Neoplasms 101Small Cell Lung Carcinoma 88Uterine Cervical Neoplasms 86Lymphoma, Non-Hodgkin 83Carcinoma, Renal Cell 72Lymphoma, Follicular 71Lymphoma 67Leukemia, Lymphocytic, Chronic, B-Cell 65Solid Tumor 64Lymphoma, Large B-Cell, Diffuse 64Hematologic Neoplasms 62

Interventions

Lasers 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × INDUSTRY × Eye Neoplasms × Clear all
NCT06643884 2026-03-13

Suprachoroidal Administration in Subjects With Metastases to the Choroid

Aura Biosciences

Phase 2 Recruiting
24 enrolled

Eye Neoplasms, Neoplasms

NCT06007690 2026-03-02

CoMpass

Aura Biosciences

Phase 3 Recruiting
100 enrolled
Dermatologic

Uveal Melanoma, Eye Neoplasms

NCT07421739 2026-02-19

Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects

Aura Biosciences

Recruiting
15 enrolled
Dermatologic

Uveal Melanoma, Eye Neoplasms

NCT07136181 2025-11-28

NBM-BMX-UM

Novelwise Pharmaceutical Corporation

Phase 1/2 Recruiting
36 enrolled
Dermatologic

Uveal Melanoma, Eye Neoplasms, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡